Stephen E. Gould - 15 Jun 2022 Form 4 Insider Report for Atreca, Inc.

Role
Chief Scientific Officer
Signature
/s/ Courtney Phillips, attorney-in-fact
Issuer symbol
N/A
Transactions as of
15 Jun 2022
Net transactions value
$0
Form type
4
Filing time
17 Jun 2022, 17:56:56 UTC
Next filing
13 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCEL Employee stock option (right to buy) Award $0 +200,000 $0.000000 200,000 15 Jun 2022 Class A Common Stock 200,000 $1.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares of Class A common stock underlying the Option shall vest on June 15, 2023 and the remainder of the shares of Class A common stock underlying the Option shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.